|
An Invitation to Attend AIRIS 2024 in Seoul
January 18, 2024
Dear International Colleague,
The FDA and the Republic of Korea’s Ministry of Food and Drug Safety are co-hosting a joint symposium on the use of artificial intelligence (AI) in medical product development on February 26-29, 2024, in Seoul.
The symposium, AIRIS 2024, will take place at The Shilla Seoul hotel in downtown Seoul and will focus on the use of AI in pharmaceuticals, biologics, and medical devices. A strong interactive dialogue is planned, covering technical and scientific issues and emerging regulatory matters. The organizers hope that this conversation will help regulators determine how to use innovative AI technologies to deliver safe and effective medical products. Speakers will be represented from government, industry, and academia.
We cordially invite you to participate in the symposium. Registration will remain open until the end of January.
To register, click on the website established for this event. For more information, please contact the AIRIS 2024 organizers at admin@airis2024.org.
###
|
|
|
|
